loading

Why is United Therapeutics Corp (UTHR) Stock down?

28 Mar, 2024:

United Therapeutics Corp (UTHR) fell by 5.57% due to a report by GuruFocus Research. This decline may have been influenced by various factors, including market sentiment and investor reactions to recent developments within the company.

  • Insider Selling Activity: Martine Rothblatt, the Chairperson & Chief Executive Officer of UTHR, sold 29,125 shares of the company on March 28, 2024, according to a recent SEC filing. This insider selling activity may have contributed to the negative sentiment surrounding UTHR stock.
  • Insider Transaction Trends: The insider trend for UTHR indicates a consistent pattern of sales by insiders over the past year, with 54 insider sells and no buys during this period. Investors often monitor insider transaction trends as they can provide insights into insiders' perspectives on the value of the company's stock.
  • Impact on stock's price: The insider selling influented the stock's price as investors raised concerns about the company and stock itself.
$84.41
price up icon 0.51%
$155.66
price down icon 0.26%
$26.14
price up icon 0.21%
$85.51
price up icon 1.16%
$221.56
price up icon 32.59%
$439.26
price up icon 10.84%
Cap:     |  Volume (24h):